← Leaderboards
Simon N Powell
Massachusetts General Hospital
$16,981,652
Attributed
$24,899,994
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,560,300 · 15
By mechanism
P50$15,954,423 · 6
R01$9,491,681 · 6
K12$7,536,900 · 1
U10$4,571,296 · 1
R13$6,000 · 1
Top collaborators
- Carol Aghajanian8 shared
- Martin S Tallman8 shared
- Oliver Zivanovic8 shared
- Renier Joseph Brentjens6 shared
- Omar Abdel-Wahab5 shared
- Michael J Morris5 shared
- Clifford Hudis3 shared
- David R Spriggs3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Philip J Goulder$10,345,162
- Leif W Ellisen$14,503,955
- Guillermo J. Tearney$42,608,505
- Chelsea Lowther$521,028
- Hiroaki Wakimoto$2,299,893
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMemorial Sloan-Kettering Cancer CenterTranslational ResearchLinkTumorProgramsMentorsGenomic InstabilityDna RepairResponseGeneticMalignant Breast NeoplasmDna DamageHomologous RecombinationPathway InteractionsGenomeDefectProteinsBaseClinical TrialsDesignMutationPhenotypeCells
Grant awards (73)
MSK SPORE in Genomic Instability in Breast Cancer$1,230,080
P50 · FY2025 · CA · contact PI
MSK Paul Calabresi Career Development Award for Clinical Oncology$804,720
K12 · FY2025 · CA · contact PI
Backup DNA repair in homologous recombination deficient cancers$487,393
R01 · FY2025 · CA · contact PI
MSK SPORE in Genomic Instability in Breast Cancer$2,348,168
P50 · FY2024 · CA · contact PI
MSK Paul Calabresi Career Development Award for Clinical Oncology$720,882
K12 · FY2024 · CA · contact PI
Defining and Targeting Homologous Recombination Deficiency in Breast Cancer$474,520
P50 · FY2024 · CA · contact PI
Administrative Core$120,519
P50 · FY2024 · CA · contact PI
Career Enhancement Program$76,271
P50 · FY2024 · CA · contact PI
MSK SPORE in Genomic Instability in Breast Cancer$2,274,787
P50 · FY2023 · CA · contact PI
MSK Paul Calabresi Career Development Award for Clinical Oncology$746,534
K12 · FY2023 · CA · contact PI
Defining and Targeting Homologous Recombination Deficiency in Breast Cancer$465,347
P50 · FY2023 · CA · contact PI
Administrative Core$111,346
P50 · FY2023 · CA · contact PI
Career Enhancement Program$67,098
P50 · FY2023 · CA · contact PI
MSK SPORE in Genomic Instability in Breast Cancer$2,274,787
P50 · FY2022 · CA · contact PI
MSK Paul Calabresi Career Development Award for Clinical Oncology$769,210
K12 · FY2022 · CA · contact PI
Defining and Targeting Homologous Recombination Deficiency in Breast Cancer$449,058
P50 · FY2022 · CA · contact PI
Administrative Core$126,919
P50 · FY2022 · CA · contact PI
Career Enhancement Program$86,648
P50 · FY2022 · CA · contact PI
MSK SPORE in Genomic Instability in Breast Cancer$2,274,787
P50 · FY2021 · CA · contact PI
MSK Paul Calabresi Career Development Award for Clinical Oncology$769,210
K12 · FY2021 · CA · contact PI
Defining and Targeting Homologous Recombination Deficiency in Breast Cancer$465,347
P50 · FY2021 · CA · contact PI
Administrative Core$111,346
P50 · FY2021 · CA · contact PI
Career Enhancement Program$67,098
P50 · FY2021 · CA · contact PI
MSK SPORE in Genomic Instability in Breast Cancer$2,257,697
P50 · FY2020 · CA · contact PI
MSK Paul Calabresi Career Development Award for Clinical Oncology$769,210
K12 · FY2020 · CA · contact PI
Defining and Targeting Homologous Recombination Deficiency in Breast Cancer$462,413
P50 · FY2020 · CA · contact PI
Administrative Core$126,113
P50 · FY2020 · CA · contact PI
Career Enhancement Program$84,074
P50 · FY2020 · CA · contact PI
MSK Paul Calabresi Career Development Award for Clinical Oncology$808,012
K12 · FY2019 · CA · contact PI
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center$922,200
U10 · FY2018 · CA
MSK Paul Calabresi Career Development Award for Clinical Oncology$696,704
K12 · FY2018 · CA · contact PI
The Response to a Site-Specific Blocked DNA Replication Fork in Human Cancers$364,993
R01 · FY2018 · CA · contact PI
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center$145,357
U10 · FY2018 · CA
MSK Paul Calabresi Career Development Award for Clinical Oncology$761,904
K12 · FY2017 · CA · contact PI
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center$737,200
U10 · FY2017 · CA
Connections and redundancy in the BRCA1-BRCA2 pathway of homologous recombination$366,860
R01 · FY2017 · CA · contact PI
The Response to a Site-Specific Blocked DNA Replication Fork in Human Cancers$364,993
R01 · FY2017 · CA · contact PI
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center$154,939
U10 · FY2017 · CA
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center$737,200
U10 · FY2016 · CA
MSK Paul Calabresi Career Development Award for Clinical Oncology$636,514
K12 · FY2016 · CA · contact PI
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center$400,000
U10 · FY2016 · CA
Connections and redundancy in the BRCA1-BRCA2 pathway of homologous recombination$366,860
R01 · FY2016 · CA · contact PI
The Response to a Site-Specific Blocked DNA Replication Fork in Human Cancers$364,993
R01 · FY2016 · CA · contact PI
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center$737,200
U10 · FY2015 · CA
Connections and redundancy in the BRCA1-BRCA2 pathway of homologous recombination$366,860
R01 · FY2015 · CA · contact PI
The Response to a Site-Specific Blocked DNA Replication Fork in Human Cancers$364,993
R01 · FY2015 · CA · contact PI
MSK Paul Calabresi Career Development Award for Clinical Oncology$54,000
K12 · FY2015 · CA · contact PI
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center$737,200
U10 · FY2014 · CA
The Response to a Site-Specific Blocked DNA Replication Fork in Human Cancers$363,679
R01 · FY2014 · CA · contact PI
Connections and redundancy in the BRCA1-BRCA2 pathway of homologous recombination$355,854
R01 · FY2014 · CA · contact PI
Connections and redundancy in the BRCA1-BRCA2 pathway of homologous recombination$366,860
R01 · FY2013 · CA · contact PI
DNA Recombinational Repair: Role of the p53 Tumor Suppressor Protein$306,714
R01 · FY2010 · CA · contact PI
DNA Recombinational Repair: Role of the p53 Tumor Suppressor Protein$306,714
R01 · FY2009 · CA · contact PI
Roles of BRCA1, BRCA2 in Homologous Recombination$368,995
R01 · FY2008 · CA · contact PI
DNA Recombinational Repair: Role of the p53 Tumor Suppressor Protein$306,916
R01 · FY2008 · CA · contact PI
Radiation Oncology 2008 Gordon Research Conference$6,000
R13 · FY2008 · CA · contact PI
Roles of BRCA1, BRCA2 in Homologous Recombination$295,697
R01 · FY2007 · CA · contact PI
DNA Recombinational Repair: Role of the p53 Tumor Suppressor Protein$245,889
R01 · FY2007 · CA · contact PI
Roles of BRCA1, BRCA2 in Homologous Recombination$286,215
R01 · FY2006 · CA · contact PI
DNA Recombinational Repair: Role of the p53 Tumor Suppressor Protein$240,563
R01 · FY2006 · CA · contact PI
Roles of BRCA1, BRCA2 in Homologous Recombination$211,001
R01 · FY2005 · CA
DNA REPAIR--ROLE OF THE P53 TUMOR SUPPRESSOR PROTEIN$177,906
R01 · FY2005 · CA
Roles of BRCA1, BRCA2 in Homologous Recombination$147,749
R01 · FY2005 · CA
DNA REPAIR--ROLE OF THE P53 TUMOR SUPPRESSOR PROTEIN$102,761
R01 · FY2005 · CA
Roles of BRCA1, BRCA2 in Homologous Recombination$356,700
R01 · FY2004 · CA
DNA REPAIR--ROLE OF THE P53 TUMOR SUPPRESSOR PROTEIN$269,880
R01 · FY2004 · CA
DNA REPAIR--ROLE OF THE P53 TUMOR SUPPRESSOR PROTEIN$269,880
R01 · FY2003 · CA
AT: ERRORS IN DOUBLE STRAND BREAK REPAIR$231,976
R01 · FY2003 · CA
DNA REPAIR--ROLE OF THE P53 TUMOR SUPPRESSOR PROTEIN$269,880
R01 · FY2002 · CA
AT: ERRORS IN DOUBLE STRAND BREAK REPAIR$226,834
R01 · FY2002 · CA
DNA REPAIR--ROLE OF THE P53 TUMOR SUPPRESSOR PROTEIN$289,380
R01 · FY2001 · CA
AT: ERRORS IN DOUBLE STRAND BREAK REPAIR$221,847
R01 · FY2001 · CA
AT: ERRORS IN DOUBLE STRAND BREAK REPAIR$223,846
R01 · FY2000 · CA